Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EXACTLY!!! $$$NSAV$$$
What should be on DEC.3 ?
I feel sorry for you man, apparently you are in a wrong stock. I'M IN A WINNER!!! $$$NSAV$$$
I'm ready for Monday's GREAT NEWS. $$$NSAV$$$
Thank you my friend for recap. Happy holidays to all. :)
Yes, the time is now for $$$NSAV$$$.
Hold on to your golden shares everyone. $$$NSAV$$$
Halberd Successfully Eradicates TNF-alpha, Major Contributing Factor to Alzheimer's Disease
Jackson Center, Pennsylvania--(Newsfile Corp. - November 22, 2021) - Halberd Corporation (OTC Pink: HALB) successfully eradicated 85% of Tumor Necrosis Factor-alpha (TNF-a) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Through Halberd's patented extracorporeal process, in combination with its patent-pending laser eradication methodology, TNF-a was eliminated through exposure to tuned laser irradiation. TNF-a is an inflammatory cytokine which has been identified as a major contributor to Alzheimer's Disease, and recently has been linked to obesity.
Dr. Mitchell S. Felder, Chief Technology Officer of Halberd Corporation and a board certified attending neurologist remarked, "TNF-a has been shown to be a significant contributor to the incidence of Alzheimer's disease. Studies have shown that neuroinflammation promotes the pathological process which leads to Alzheimer's Disease1,2,3. Drugs designed to inhibit neuroinflammation are limited in their effectiveness because they are inefficient at traversing the blood-brain barrier. Our extracorporeal elimination of the TNF-a inflammatory cytokine from cerebral spinal fluid could lead to a completely new approach to the treatment of Alzheimer's Disease. A reduction in the amount of TNF-a by over 80% in such a short time is a truly remarkable achievement."
William A. Hartman, Halberd Coourrporation's Chairman, President & CEO, added, "This is the latest step in march towards finding effective treatments for PTSD, CTE and Alzheimer's Disease. We earlier reported on our successful elimination of Phosphorylated Tau from CSF, the primary building block of neurofibrillary tangles associated with Alzheimer's Disease, and Interleukin 6 (IL-6), another inflammatory cytokine associated with cognitive decline."
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7041/104578_c8bec4ccc4cc58f1_001full.jpg
"Our next steps in our research program will address the elimination from, or the regulation of levels of several other inflammatory cytokines, proteins and glutamate in CSF, which have been linked to the onset and progression of Alzheimer's disease, other neurodegenerative diseases and obesity. Our longer term objective is to continue to focus on the eradication of the remaining pathogens from CSF and blood plasma related to Alzheimer's Disease, Parkinson's Disease, Lou Gehrig's Disease, Epilepsy and Obesity."
To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter:@HalberdC
https://finance.yahoo.com/news/halberd-successfully-eradicates-tnf-alpha-130000493.html
NSAV ANNOUNCES DECEMBER 6, 2021 LAUNCH DATE FOR PRIVATE SALE OF ITS NSAVDEX NATIVE TOKEN, THE NSBC, AND ENTRY INTO MULTI-BILLION DOLLAR MARKET
London, England, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced that the Private Sale of its NSAVDEX Native Token (NSBC) will commence on December 6, 2021 at 11:00 AM EST. The Company has set aside 10 million NSBC tokens for the private sale at 0.10 USDT per token. The NSBC (NSAV Blockchain) is the native token for the recently launched NSAVDEX Decentralized Cryptocurrency Exchange https://nsavdex.org/#/home . An NSAV shareholder conference call will be announced in the coming days to inform shareholders of the financial and technical aspects of the NSBC token and private sale. For further information, please contact the Company on our official DEX Telegram at https://t.me/NSAVDEXorg .
The NSAVDEX native token will be using the OKEx Chain Protocol. OKEx https://www.okex.com/ Exchange ranks third in terms of 24 hour trading volume for Centralized Cryptocurrency Exchanges https://coinranking.com/exchange/hUlMcwWZp_+okex . The NSBC is a utility token, whose primary functions are yield farming and staking, plus a variety of additional functions. In order to ensure the highest standards are achieved, the NSBC token is being developed in cooperation with Realtize LLC. https://realtize.io/ whose main focus is on regulated digital assets.
After the recent trendsetting accomplishments by Uniswap https://uniswap.org/ NSAV management believes now is the perfect time to launch its DEX Native Token. Uniswap, the globe's largest Decentralized Cryptocurrency Exchange, had its Native Token (UNI) hit $140 in market capitalization only 7 hours after its launch. Recently, UNI reached a market capitalization of over $15 billion and a new all-time high of over $26.00. https://cointelegraph.com/news/3-reasons-why-uniswap-uni-token-hit-a-new-all-time-high-above-15
The NSAVDEX.org is a decentralized cryptocurrency exchange, where the maximum yield and leverage will be presented to participants, with the addition of NFTs, lotteries, predictions and the central features of yield farms and pools. The NSAVDEX.org will enable the Company to become a significant player in the crypto space of AI Automated Market Makers (AMM) and is proudly operated by NSAV with a professional team of financial experts and crypto geeks.
Dato’ Sri Desmond Lim, Interim CEO and Senior Vice President of Cryptocurrency Operations for NSAV and Silverbear Capital partner stated, “We are delighted to announce this private sale of our NSAVDEX native token, the NSBC. It is our intention to not release too many tokens in this private round. This launch marks another milestone for the NSAV ECO-system and furthers our commitment to provide a comprehensive digital blockchain platform to our community. We are also providing a great opportunity for our early investors to purchase the NSBC token at a preferential price."
Stanley Yu, Senior Vice President of Technology stated, “Running our NSAVDEX and related NSBC native token on OKEx gives us a solid foundation to grow and continue to offer the optimal services to our users.”
NSAV's vision is the establishment of a fully integrated technology company, which provides turnkey technological solutions to the cryptocurrency, blockchain and digital asset industries. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, financial services, advisory services and information technology.
For further information please contact NSAV at info@nsavholdinginc.com
The NSAV Twitter account can be accessed at https://twitter.com/nsavtech
The NSAV corporate website can be accessed at http://nsavholdinginc.com
The NSAV Premium OTC Crypto Trading Desk website can be accessed at https://nsavholdinginc.com/otc-desk/
The NSAV Hong Kong OTC Crypto Trading Desk website can be accessed at https://hkotc.co/
The NSAV Decentralized Cryptocurrency Exchange (DEX) website can be accessed at https://nsavdex.org/#/home
The NSAVDEX Telegram account can be accessed at https://t.me/NSAVDEXorg
Silverbear Capital Inc. https://www.sbcfinancialgroup.com.hk/, a leading, global investment banking firm, will be advising NSAV on strategic matters related to this transaction.
Silverbear Capital Inc. (SBC) has a dynamic of disciplines on a broad commercial level and practice. SBC has a strong group of Partners in a wide range of disciplines with seasoned experience in finance, management, and professional practice. https://www.sbcfinancialgroup.com.hk/meet-our-team/.
Disclaimer: Silverbear Capital Inc. does not constitute investment advice, or an offer or solicitation to sell, or a solicitation to buy, or any other investment product (nor shall any such shares or product be offered or sold to any person) in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities law of that jurisdiction.
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person.
Contact
Net Savings Link, Inc.
info@nsavholdinginc.com
https://finance.yahoo.com/news/nsav-announces-december-6-2021-142000002.html
Hello everyone. NSAV financial looks much better than I expected. Looking to the great end of 2021 and super 2022. $$$NSAV$$$.
NEXT WEEK WILL BE BETTER!!! $$$NSAV$$$
Thanks Bonus for the great job of posting this. Our time will come. $$$NSAV$$$
In a mean time we shouldn't expect anything good from financials, it's too early for this. But I'm sure that company is working hard and shareholders will be milliners. $$$NSAV$$$
Hey Potato, don't get baked. LOL. $$$NSAV$$$.
Hey Potato, wrong answer. The lower PPS doesn't make it good money for him or associates regardless of number of shares.
Company is moving forward but apparently it's not enough. We need a big and undisputed achievement to really move PPS UP so even JT's big lies wouldn't be able to effect it. Why JT lies knowing that he is hurting his stock? And why his associates let him do it?
STAY STRONG!!! $$$NSAV$$$
Guys, lets stay on topic. The only topic on this board is NSAV stock. I have better things to do than delete your speeches and some of them are really stupid.
Buys 24 Mil, Sells 21 Mil. $$$NSAV$$$.
Thanks.
Thanks.
Can somebody repost BW's tweets from today? Thank you.
So don't repeat and don't quote it. GLTY. :)
JT is no issue here and I don't care about him at all unless you are a flipper. $$$NSAV$$$ is one of the kind company and will grow like this.
NO WAY!!! $$$NSAV$$$
JT what I think about you I'll keep for myself, but NSAV is moving forward even if not so fast as I would hope. STRONG HOLD>
Back home and ready for the good news. $$$NSAV$$$
THANK U ALL. NSAV.$$$$$$$$$$$$$$
$$$NSAV$$$ from Hawaii!!! GlTA
Aloha everyone from beautiful Waikikii. My very best wishes to all Nsav'ers! Stay long and strong and we will win. $$$NSAV$$$.
The difference is $$$$$$$$$$$. Going to Hawaii. Want good news upon arrival. GLTA. $$$NSAV$$$
$$$NSAV$$$
Halberd Successfully Eradicates IL-6, a Critical Factor in PTSD, CTE & Alzheimer’s Disease
Press Release | 11/01/2021
Elevated levels of IL-6 are believed to be causal factors in PTSD, Chronic Traumatic Encephalopathy, & Alzheimer's Disease.
JACKSON CENTER, PA / ACCESSWIRE / November 1, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 100% of IL-6 from synthetic cerebral spinal fluid (CSF) in preliminary testing. Through its patented extracorporeal process in combination with its patent-pending laser eradication process, IL-6 was virtually eliminated in as little as three minutes of laser radiation exposure. Elevated levels of IL-6 in CSF have been linked to various neurological disorders.
Dr. Mitchell S. Felder, Chief Technology Officer of Halberd Corporation and a board certified attending neurologist remarked, "The spontaneous production of IL-6 has been shown to be significantly higher in PTSD patients. This has directly correlated with PTSD symptom severity within the PTSD patient group. Practicing psychiatrists have stated they believe that the precisely controlled elimination of IL-6 and other inflammatory cytokines in CSF (cerebrospinal fluid) could be a very major breakthrough against PTSD and suicidal depression. Our recent breakthrough historic achievements with our university partners, position us to achieve that goal in medical practice."
William A. Hartman, Halberd Corporation's Chairman, President & CEO, added, "This is the next step in our march towards finding effective treatments for PTSD, CTE and Alzheimer's Disease. Previously, we successfully eliminated Phosphorylated Tau from CSF, the primary building block of neurofibrillary tangles associated with Alzheimer's Disease. Now that the quality problems have been eliminated from our purchased materials, we expect rapid progress ahead toward the final steps with these historic accomplishments.
"The next steps in our research program include verification testing related to IL-6 elimination from CSF, then moving on to eliminating Tumor Necrosis Factor - Alpha (TNF-a) and ultimately Glutamate from CSF. When we successfully eliminate these pathogens, we will approach the military for endorsement/support. Meanwhile, our longer term objective is to continue to focus on the eradication of the remaining pathogens from CSF and blood plasma related to Alzheimer's Disease, Parkinson's Disease, Lou Gehrig's Disease, Epilepsy and Obesity."
To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter:@HalberdC
About Halberd Corporation.
Halberd Corporation (OTC-PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. It holds the exclusive worldwide rights to numerous patent- and PCT-pending extracorporeal treatments for COVID-19, PTSD, Alzheimer's Disease, and other medical maladies. Halberd also holds the exclusive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287 and an allowed but not yet issued patent for the treatment of Cockayne Syndrome.
https://www.otcmarkets.com/stock/HALB/news/Halberd-Successfully-Eradicates-IL-6-a-Critical-Factor-in-PTSD-CTE--Alzheimers-Disease?id=328279
Waikiki.
Totally agree! GLTY! $$$NSAV!!!
Get a nice one and GLTA.
Move to Silicon Valley whre I'm on Soc Sec. LOL.
No, but on a bright side still beats capital loses. :)
Thank you, I can't say I like it. I don't want status update, I want to see "closed" and document with the proof.
Did you have a link or tweet from today about "it's coming"?